Diagnostic Yield of Cardiac CT to Detect Cardiac Thrombi in Acute Ischemic Stroke: an Individual Patient Data Meta-Analysis
NCT ID: NCT07165093
Last Updated: 2026-01-21
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
3940 participants
OBSERVATIONAL
2018-05-19
2025-09-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The main analysis will investigate the diagnostic yield of cardiac CT to detect cardioembolic sources of stroke in acute ischemic stroke patients.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Detecting Cardiac Thrombi in Acute Ischemic Stroke on Cardiac CT Versus Transoesophageal Echocardiography
NCT06585228
Ultra-high-resolution CT vs. Conventional Angiography for Detecting Coronary Heart Disease
NCT04272060
Microembolic Detection in Acute Ischemic Stroke Patients With Atrial Fibrillation and Outcome
NCT06018090
Myocardial Contrast Echocardiography for the Assessment of the Infarct Related Artery & Risk Area in Patients w/ NSTEMI.
NCT02014701
Coronary Arteriosclerosis in Patients With Acute Ischemic Stroke
NCT00701818
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Prospectively planned subanalyses from the AIS of HEARTS registry:
Beyond the analyses focussed on cardiac thrombi, the investigators have prespecified the following analyses:
* Risk stratification of cardioembolic sources in acute ischemic stroke to improve decision making in performing a cardiac CT
* Short term clinical implications of cardiac thrombi detected on cardiac CT
* Long term clinical implications of cardiac thrombi detected on cardiac CT
* Diagnostic yield of ECG-gated versus non-ECG-gated cardiac CT in the acute phase of ischemic stroke
* Association between left atrial appendage contrast filling characteristics and recurrent stroke
* Association between left atrial appendage (LAA) morphology/volume and LAA thrombus
* Cardiac thrombus and associations with medium vessel occlusions strokes
* High-risk cardioembolic sources on cardiac CT in TIA patients
* Clinical relevance of valvular vegetations detected on cardiac CT
* Long term clinical implications of left atrial diverticula detected on cardiac CT
* Incidental findings on cardiac CT The investigators are planning to perform these additional analyses once the main paper has been accepted/submitted.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
OTHER
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Amsterdam UMC
Patients from Amsterdam UMC that underwent ECG-gated cardiac CT
No interventions assigned to this group
Christchurch Hospital
Patients from Christchurch hospital that underwent non-ECG gated cardiac CT
No interventions assigned to this group
John Hunter Hospital
Patients from John Hunter Hospital that underwent non-ECG gated cardiac CT
No interventions assigned to this group
Liverpool Hospital
Patients from Liverpool Hospital that underwent ECG-gated cardiac CT
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Clinical diagnosis of acute ischemic stroke
* Cardiac CT acquired during acute stroke scan protocol
Exclusion Criteria
* Stroke mimics
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Jonathan Coutinho
Principal Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jonathan Coutinho, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
Amsterdam UMC
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Amsterdam UMC
Amsterdam, , Netherlands
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
NL64139.018.18
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.